Does PEGCETACOPLAN Cause Haemolysis? 100 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Haemolysis have been filed in association with PEGCETACOPLAN (Empaveli). This represents 7.3% of all adverse event reports for PEGCETACOPLAN.
100
Reports of Haemolysis with PEGCETACOPLAN
7.3%
of all PEGCETACOPLAN reports
1
Deaths
57
Hospitalizations
How Dangerous Is Haemolysis From PEGCETACOPLAN?
Of the 100 reports, 1 (1.0%) resulted in death, 57 (57.0%) required hospitalization, and 3 (3.0%) were considered life-threatening.
Is Haemolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGCETACOPLAN. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does PEGCETACOPLAN Cause?
Fatigue (135)
Visual impairment (125)
Haemoglobin decreased (106)
Off label use (97)
Vitreous floaters (78)
Breakthrough haemolysis (67)
Headache (66)
Product dose omission issue (59)
Uveitis (59)
Covid-19 (56)
What Other Drugs Cause Haemolysis?
ECULIZUMAB (1,476)
HUMAN IMMUNOGLOBULIN G (357)
RITUXIMAB (261)
RAVULIZUMAB-CWVZ (242)
PREDNISONE (192)
CYCLOSPORINE (173)
DEXAMETHASONE (167)
ACETAMINOPHEN (134)
VINCRISTINE (132)
TACROLIMUS (116)
Which PEGCETACOPLAN Alternatives Have Lower Haemolysis Risk?
PEGCETACOPLAN vs PEGFILGRASTIM
PEGCETACOPLAN vs PEGFILGRASTIM-APGF
PEGCETACOPLAN vs PEGFILGRASTIM-BMEZ
PEGCETACOPLAN vs PEGFILGRASTIM-CBQV
PEGCETACOPLAN vs PEGFILGRASTIM-JMDB